title: Ascorbyl palmitate vesicles (Aspasomes): formation, characterization and applications.
abstract: Vesicles with biological activity or with a targeting function in addition to carrier properties will have an added advantage. Vesicles prepared with amphiphiles having antioxidant property may have potential applications towards disorders implicated with reactive oxygen species. Ascorbyl palmitate (ASP) was explored as bilayer vesicle forming material. It formed vesicles (Aspasomes) in combination with cholesterol and a negatively charged lipid (dicetyl phosphate). Aspasomes were prepared by film hydration method followed by sonication in which aqueous azidothymidine (AZT) solution was encapsulated in aqueous regions of bilayer. Aspasomes were obtained with all compositions containing 18-72 mol% cholesterol. Differential scanning calorimetric data of aspasome dispersion and anhydrous mixtures of ascorbyl palmitate, cholesterol and dicetyl phosphate confirm the formation of bilayered vesicles with ascorbyl palmitate. Cholesterol content in aspasome did not exhibit any relation with vesicle size, zeta potential or percent entrapment. A substantial change in release rate of azidothymidine from aspasome was noticed on varying the proportion of cholesterol. Release rate and cholesterol content in Aspasomes did not exhibit any relation. A preparation with 45 mol% of cholesterol showed maximum retardation in release rate, than other compositions. The change in capture volume with time (latency) was studied for 8 h and with such a short duration study it was difficult to predict long term stability of these vesicles. But release experiments do indicate stability up to 18 h. Percent reducing activity of aspasome was estimated by measuring the absorbance of alpha,alpha-diphenyl-beta-picrylhydrazyl (DPPH) at 517 nm after addition of test antioxidant samples. These studies revealed that the antioxidant potency of ascorbyl moiety is retained even after converting ascorbyl palmitate into vesicles (Aspasomes). The antioxidant potency of Aspasomes was assessed by measuring the protection offered by this preparation against quinolinic acid induced lipoperoxidation of whole human blood in vitro, where in the lipoperoxidation was monitored by measuring thiobarbituric acid reactive substances (TBARS) levels. Aspasome rendered much better antioxidant activity than ascorbic acid. Transdermal permeation of aspasomal AZT, ASP-AZT aqueous dispersion and AZT-solution across excised rat skin was investigated in vitro using Franz diffusion cell. Permeation of aspasomal AZT was much higher than the other two preparations. However, ASP-AZT aqueous dispersion has also enhanced permeation of AZT significantly over the AZT-solution, indicating skin permeation enhancing property of ascorbyl palmitate.
authors.affiliation: University College of Pharmaceutical Sciences, Kakatiya University, Warangal 506009, A.P., India.
authors.forename: D
authors.initials: D
authors.lastname: Gopinath
authors.forename: D
authors.initials: D
authors.lastname: Ravi
authors.forename: B R
authors.initials: BR
authors.lastname: Rao
authors.forename: S S
authors.initials: SS
authors.lastname: Apte
authors.forename: D
authors.initials: D
authors.lastname: Renuka
authors.forename: D
authors.initials: D
authors.lastname: Rambhau
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics; D001205:Ascorbic Acid / Q000031:analogs & derivatives* / Q000737:chemistry*; D002152:Calorimetry, Differential Scanning; D002626:Chemistry, Pharmaceutical; D002784:Cholesterol / Q000737:chemistry; D004337:Drug Carriers / Q000737:chemistry*; D004355:Drug Stability; D066298:In Vitro Techniques; D008051:Lipid Bilayers / Q000737:chemistry; D015227:Lipid Peroxidation; D010755:Organophosphates / Q000737:chemistry; D010316:Particle Size; D051381:Rats; D012869:Skin Absorption; D012995:Solubility; D015215:Zidovudine / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics
chemical_list: D000975:Antioxidants; D004337:Drug Carriers; D008051:Lipid Bilayers; D010755:Organophosphates; C002290:dicetylphosphate; D015215:Zidovudine; D002784:Cholesterol; D001205:Ascorbic Acid; C031226:6-O-palmitoylascorbic acid